Literature DB >> 22517176

Mini-drainage devices: the Ex-PRESS Mini-Glaucoma Device.

J Matthew Rouse1, Steven R Sarkisian.   

Abstract

The Ex-PRESS Mini-Glaucoma Device is a glaucoma drainage device used to shunt aqueous from the anterior chamber into a subconjunctival reservoir that is created surgically. It has been used successfully over the last decade with approximately 60,000 implantations worldwide. In an ever-evolving microsurgical environment, the Ex-PRESS glaucoma device is on the forefront of intraocular pressure lowering technology. This chapter aims to review the surgical uses, techniques and considerations of the Ex-PRESS device as well as analyze the current literature detailing the advantages and disadvantages of the Ex-PRESS implant. Special attention will also be placed on the authors' own experience using the device.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22517176     DOI: 10.1159/000334780

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  4 in total

1.  Efficacy and economic analysis of Ex-PRESS implantation versus trabeculectomy in uncontrolled glaucoma: a systematic review and Meta-analysis.

Authors:  Ling Wang; Fang Sha; Da-Dong Guo; Hong-Sheng Bi; Jun-Kang Si; Yu-Xiang Du; Kai Tang
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

2.  Ex-PRESS implantation versus trabeculectomy in uncontrolled glaucoma: a meta-analysis.

Authors:  Wei Wang; Minwen Zhou; Wenbin Huang; Xiulan Zhang
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

3.  ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient.

Authors:  Bonnie Nga Kwan Choy; Mandy Oi Man Wong; Jonathan Cheuk Hung Chan; Connie Hong Yee Lai; Jimmy Shiu Ming Lai
Journal:  Case Rep Ophthalmol       Date:  2016-12-01

4.  Evaluation of Ex-PRESS implantation combined with phacoemulsification in primary angle-closure glaucoma.

Authors:  Bing Liu; Da-Dong Guo; Xiu-Juan Du; Chen-Yang Cong; Xiao-Hua Ma
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.